Skip to main content
. 2018 Sep;94(3):1007–1030. doi: 10.1124/mol.118.112730

Fig. 9.

Fig. 9.

Predicted effects profiles for ADIs based on preclinical discovery research models (published and on-file data). (A) Effects of HDM exposure in the airways with a focus on innate immune responses. (B) Example effects of HDM exposure in the presence of ADI drug, with affected pathways grayed out. GMCSF, granulocyte macrophage-colony stimulating factor.